Loading company…
Vial provides clinical trial infrastructure and software for trials across several therapeutic areas.
Founded in 2020 by Andrew Brackin and Simon Burns and based in California, Vial provides technology and services for clinical trials in oncology, dermatology, ophthalmology, gastroenterology, neurology, and cardiology. Its Vial CRO platform supports trial operations from site startup to database lock, with electronic source and CRA tools. In November 2022, it raised Series B funding led by General Catalyst Partners, with participation from BoxGroup and Byers Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in